Error: Could not add to watchlist. X
+ Watchlist

Genmab A/S

GEN:DC
Copenhagen
1,411.00
DKK
15.00
1.07%
As of 3:15 AM EDT 6/29/2017
Open
1,407.00
Day Range
1,406.00 - 1,415.00
Volume
29,079
Previous Close
1,396.00
52Wk Range
970.00 - 1,489.00
1 Yr Return
20.77%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
1,407.00
Day Range
1,406.00 - 1,415.00
Volume
29,079
Previous Close
1,396.00
52Wk Range
970.00 - 1,489.00
1 Yr Return
20.77%
YTD Return
20.29%
Current P/E Ratio (TTM)
68.26
Earnings per Share (DKK) (TTM)
20.45
Market Cap (b DKK)
85.094
Shares Outstanding (m)
60.955
Price/Sales (TTM)
44.41
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.53%
% Price Change
+0.52%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Genmab A/S is a biotechnology company. The Company creates and develops human antibody products for the treatment of life threatening and debilitating diseases. Genmab focuses on products to treat cancer, rheumatoid arthritis and other inflammatory conditions, and psoriasis. The Company develops new products through partnerships. Genmab operates in Europe and the United States.
Address
Bredgade 34E
Copenhagen K, 1260
Denmark
Phone
45-7020-2728
  • Jan G J Van De Winkel
    President/CEO/Co-Founder
  • David A Eatwell
    EVP/CFO
  • Judith Klimovsky
    EVP/Chief Development Ofcr
  • Paul W H I Parren
    SVP/Dir:Scientific
  • Michael K Bauer
    SVP:Clinical Development
Show More